Filtrer par catégorie
- Tous
- Congress
- Blog
- Congrès
- Ressource Scientifique
- Webinaire
- Poster
- Publication scientifique
- Communiqué de Presse
- Couverture presse
- Actualités
Filtrer par catégorie
Actualités
25/10/2024
Oncology CRO of the year 2024 – FRANCE
Oncodesign Services is thrilled to announce that we have been awarded "Oncology CRO of the year 2024 – France"!
Blog
10/10/2024
The Game-Changing Role of Artificial Intelligence in Drug Discovery
Discover in this blog how Artificial Intelligence (AI) has a game-changing role in drug discovery and computational chemistry
Blog
24/09/2024
Radionuclides: a sourcing challenge
In this blog, we deal with overcoming radionuclides supply challenges with innovative solutions by Oncodesign Services
Actualités
21/05/2024
Meet Mylinda, In vitro Study & research technician
Learn more about her job, techniques and projects she performs regularly in our in vitro platform to contribute to drug development
Congress
15/05/2024
BIO US 2024 – Oncodesign Services and ZoBio
Oncodesign Services and ZoBio will be attending to Bio US 2024 ! Fix a meeting now
Publication scientifique
13/05/2024
How Oncodesign Services contributed to the Development of a New COVID-19 Vaccine
Oncodesign Services provided valuable support in bioanalysis and dosage for the development on new vaccine against COVID-19.
Publication scientifique
07/05/2024
Meeting with Patrick Jimonet (Medicen)
In this interview, discover how Patrick Jimonet led and united over thirty prominent international experts to develop proposals aimed at facilitating the integration of the microbiome into drug discovery. 💊
Webinaire
24/04/2024
How to target RNA modulation with small molecule?
In this two-part free webinar series, we've assembled a team of leading experts who will delve into the intricacies of RNA modulation, explore its potential applications, and showcase real-world case studies.
Poster
07/04/2024
Intra-cranial administration of MTL-004, a promising post-resection treatment for glioblastoma
Gliomas (GBM), are exceptionally hard to treat, aggressive and genetically heterogeneous tumors. Read the poster to discover the case study!
Poster
07/04/2024
Evaluation of checkpoint inhibitor efficacy in a humanized immune system mouse model lacking murine Fc gamma receptors
Humanized immune system (HIS) mice are critical immuno-oncology tools for evaluating antibody-based therapeutic target engagement and efficacy in a human-like context
Poster
07/04/2024
New technologies and capabilities supporting the development of novel Molecular RadioTherapy agents
Read our Oncodesign-Services' poster which provides cutting-edge technologies and products to support the development of radiopharmaceuticals for theranostics.
Poster
07/04/2024
Examples of translational preclinical models to mimic cancer drug resistance
Resistance mechanisms are now well studied in vitro, based on mutated cell lines for specific resistance pathways. Discover our poster!